TSX:CRONPharmaceuticals
Cronos Group (TSX:CRON) Revenue Jump To US$44.5 Million Tests Profitability Narrative
Cronos Group (TSX:CRON) closed FY 2025 with Q4 revenue of US$44.5 million and a basic EPS loss of US$0.00, alongside trailing twelve month revenue of US$146.6 million and a basic EPS loss of US$0.02. The company has seen quarterly revenue move from US$30.3 million in Q4 2024 to US$44.5 million in Q4 2025, while basic EPS has shifted between a profit of US$0.11 in Q4 2024 and a small loss in the latest quarter. This sets up a story in which investors will be watching how quickly margins can...